Zenith Healthcare (BOM:530665) EBIT: ₹0.2 Mil (TTM As of Mar. 2026)


BOM:530665 Zenith Healthcare Ltd BOM:530665
64 GF Score
Price ₹3.07
GF Value ₹3.65
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Zenith Healthcare EBIT?

Zenith Healthcare BOM:530665 +0.66% 64 EBIT is ₹0.2 Mil as of Mar. 2026. GuruFocus rates BOM:530665 with a GF Score™ of 64/100 and a GF Value™ of ₹3.65 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Zenith Healthcare's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was ₹-4.2 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.2 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Zenith Healthcare's annualized ROC % for the quarter that ended in Mar. 2026 was -19.06%. Zenith Healthcare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -36.30%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Zenith Healthcare's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 0.18%.


Zenith Healthcare  (BOM:530665) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Zenith Healthcare's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-20.716 * ( 1 - 19.21% )/( (0 + 87.814)/ 1 )
=-16.7364564/87.814
=-19.06 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Zenith Healthcare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-16.848/( ( (0 + max(0, 0)) + (14.527 + max(31.88, 0)) )/ 1 )
=-16.848/( ( 0 + 46.407 )/ 1 )
=-16.848/46.407
=-36.30 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0 + 0 + 0)
=0

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(20.914 + 29.234 + 17.345) - (15.022 + 0 + 20.591)
=31.88

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Zenith Healthcare's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=0.247/138.677
=0.18 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zenith Healthcare EBIT Related Terms


Zenith Healthcare EBIT Historical Data

* Premium members only.

The historical data trend for Zenith Healthcare's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zenith Healthcare EBIT Chart

Zenith Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.06 1.18 5.77 2.91 0.25

Zenith Healthcare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.54 -0.22 2.20 2.48 -4.21

BOM:530665 vs ZTS, UTHR: EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Zenith Healthcare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zenith Healthcare EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zenith Healthcare's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Zenith Healthcare's EV-to-EBIT falls into.


BOM:530665
64GF Score
Zenith Healthcare Ltd BOM:530665
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zenith Healthcare EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₹0.2 Mil mean?
Zenith Healthcare (BOM:530665) has a EBIT of ₹0.2 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Zenith Healthcare.
Is Zenith Healthcare's EBIT too high?
Zenith Healthcare's current EBIT is ₹0.2 Mil. Overall, Zenith Healthcare has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zenith Healthcare's EBIT compare to ZTS and UTHR?
Zenith Healthcare's EBIT of ₹0.2 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Drug Manufacturers company?
A good EBIT depends on the Drug Manufacturers industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Zenith Healthcare. Zenith Healthcare's current EBIT is ₹0.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zenith Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Zenith Healthcare (BOM:530665) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹3.65, compared to a current price of ₹3.07 — trading 15.9% below its estimated fair value. The current EBIT is ₹0.2 Mil. Zenith Healthcare's overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Zenith Healthcare (BOM:530665), the current EBIT is ₹0.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zenith Healthcare (BOM:530665) Overvalued in 2026?

Based on GuruFocus' analysis, Zenith Healthcare stock appears to be undervalued. The current stock price of ₹3.07 is trading 15.9% below its estimated GF Value™ of ₹3.65. GuruFocus considers Zenith Healthcare to be Modestly Undervalued.

Key valuation signals for BOM:530665:

  • EBIT: ₹0.2 Mil
  • GF Value™: ₹3.65 vs. price of ₹3.07 (15.9% below fair value)
  • GF Score™: 64/100 with 5 warning signs

No single metric tells the full story. See the BOM:530665 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zenith Healthcare Business Description

Address Prahladnagar Cross Road, S. G. Road, 504, Iscon Elegance, Near Ananddham Jain Derasar, Ahmedabad, GJ, IND, 380051
Zenith Healthcare Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and trading of pharmaceutical formulations. The company also undertakes contracts for manufacturing business. It manufactures pharmaceutical formulations in the form of Tablets, Capsules, Oral liquids, and injectables. The company sells its products in India and also exports internationally.
64GF Score

Get the complete analysis for BOM:530665

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹3.07
Price
₹3.65
GF Value